Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

There's a Lot to Like in AbbVie's Q3 Update

TheMotleyFool 
0 0 27.10.17
There's a Lot to Like in AbbVie's Q3 Update
 
There's a Lot to Like in AbbVie's Q3 Update

AbbVie (NYSE: ABBV) has set a pattern in recent quarters of meeting or barely exceeding consensus analysts' earnings estimates. It's not that the big biotech hasn't performed well; rather, expectations have been pretty high for AbbVie.

That was the case once more for AbbVie entering the third quarter. The company announced its earnings results before the market opened on Friday. AbbVie yet again turned in a strong performance. And it yet again narrowly topped earnings estimates. Here are the highlights. 

Image source: Getty Images.

Continue reading


Source: Fool.com

AbbVie Inc. Stock

€157.50
1.600%
There is an upward development for AbbVie Inc. compared to yesterday, with an increase of €2.48 (1.600%).
With 23 Buy predictions and not a single Sell prediction AbbVie Inc. is an absolute favorite of our community.
With a target price of 174 € there is a slightly positive potential of 10.48% for AbbVie Inc. compared to the current price of 157.5 €.
Show more
Like: 0
ABBV
Share

Comments

Not a member yet? Sign up for free!